See more : Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of PT Unggul Indah Cahaya Tbk (UNIC.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Unggul Indah Cahaya Tbk, a leading company in the Chemicals industry within the Basic Materials sector.
- Anhui Landun Photoelectron Co., Ltd. (300862.SZ) Income Statement Analysis – Financial Results
- RAVENO Capital AG (TUF.DE) Income Statement Analysis – Financial Results
- zSpace, Inc. Common stock (ZSPC) Income Statement Analysis – Financial Results
- Gaming Innovation Group Inc. (GIGSEK.ST) Income Statement Analysis – Financial Results
- UAS Drone Corp. (USDR) Income Statement Analysis – Financial Results
PT Unggul Indah Cahaya Tbk (UNIC.JK)
About PT Unggul Indah Cahaya Tbk
PT Unggul Indah Cahaya Tbk engages in the manufacture and sale of alkylbenzene chemicals for use as primary raw material to produce detergents in Indonesia. The company operates in two segments, Chemicals and Real Estate. It offers linear and branched alkylbenzene, as well as heavy and light alkylate. The company also manufactures and distributes active detergents of linear alkylbenzene sulfonic acid and sodium lauryl ether sulfate, sodium tripolyphosphate, and phosphates and surfactants. In addition, it is involved in the development of real estate properties; trading and investment activities; and retail of consumer products. The company exports its products to Vietnam, Malaysia, Thailand, Australia, Japan, China, the Netherland, and France. PT Unggul Indah Cahaya Tbk was founded in 1983 and is headquartered in Jakarta Selatan, Indonesia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 339.30M | 412.08M | 371.08M | 324.96M | 322.10M | 350.40M | 320.55M | 276.11M | 285.42M | 400.09M | 439.00M | 460.24M | 461.60M |
| Cost of Revenue | 293.73M | 338.61M | 277.12M | 269.51M | 288.18M | 317.85M | 281.49M | 241.87M | 262.51M | 371.81M | 393.27M | 420.07M | 422.38M |
| Gross Profit | 45.57M | 73.47M | 93.96M | 55.45M | 33.92M | 32.55M | 39.06M | 34.25M | 22.91M | 28.29M | 45.72M | 40.17M | 39.23M |
| Gross Profit Ratio | 13.43% | 17.83% | 25.32% | 17.06% | 10.53% | 9.29% | 12.18% | 12.40% | 8.03% | 7.07% | 10.42% | 8.73% | 8.50% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.03M | 2.71M | 2.66M | 2.57M | 2.59M | 2.28M | 2.63M | 11.70M | 12.67M | 13.62M | 15.65M | 17.32M | 16.86M |
| Selling & Marketing | 7.15M | 8.91M | 8.59M | 7.10M | 6.25M | 7.08M | 7.68M | 8.55M | 6.38M | 8.40M | 9.18M | 9.52M | 9.09M |
| SG&A | 9.18M | 11.62M | 11.25M | 9.67M | 8.85M | 9.36M | 10.31M | 20.25M | 19.05M | 22.02M | 24.83M | 26.84M | 25.95M |
| Other Expenses | 10.34M | 10.47M | 9.73M | 10.32M | 10.07M | 495.20K | 514.47K | -52.07K | -23.32K | -652.86K | -4.55M | -1.95M | -732.43K |
| Operating Expenses | 19.52M | 22.09M | 20.98M | 19.98M | 18.92M | 18.41M | 21.34M | 20.19M | 18.23M | 21.37M | 20.28M | 24.89M | 25.22M |
| Cost & Expenses | 313.25M | 360.70M | 298.10M | 289.49M | 307.09M | 336.25M | 302.83M | 262.06M | 280.73M | 393.18M | 413.56M | 444.95M | 447.59M |
| Interest Income | 2.81M | 1.20M | 1.47M | 826.20K | 296.15K | 206.85K | 200.04K | 299.28K | 172.65K | 144.99K | 157.62K | 248.55K | 362.39K |
| Interest Expense | 522.93K | 254.56K | 284.28K | 197.37K | 1.37M | 2.10M | 1.41M | 2.21M | 2.07M | 2.50M | 2.98M | 3.33M | 3.37M |
| Depreciation & Amortization | 926.86K | 1.03M | 462.15K | 463.42K | 5.40M | 222.83K | 361.12K | 5.43M | -671.36K | -1.03M | -718.85K | 6.21M | 300.20K |
| EBITDA | 29.31M | 50.03M | 74.28M | 38.93M | 20.89M | 30.24M | 19.42M | 13.97M | 2.46M | 4.26M | 21.88M | 14.98M | 12.07M |
| EBITDA Ratio | 8.64% | 11.54% | 19.96% | 12.55% | 4.49% | 3.67% | 6.06% | 5.20% | 0.86% | 1.06% | 4.98% | 3.25% | 2.75% |
| Operating Income | 26.05M | 48.49M | 72.72M | 37.35M | 15.25M | 29.74M | 18.43M | 14.31M | 3.13M | 5.26M | 22.59M | 8.77M | 12.40M |
| Operating Income Ratio | 7.68% | 11.77% | 19.60% | 11.49% | 4.73% | 8.49% | 5.75% | 5.18% | 1.10% | 1.31% | 5.14% | 1.91% | 2.69% |
| Total Other Income/Expenses | 2.34M | 473.38K | 1.14M | 1.10M | -1.50M | 13.41M | -847.95K | -2.90M | -3.91M | -4.68M | -1.53M | -8.43M | -3.70M |
| Income Before Tax | 28.39M | 48.74M | 73.53M | 38.27M | 13.74M | 28.14M | 17.65M | 11.41M | -101.99K | 1.73M | 18.90M | 4.78M | 8.69M |
| Income Before Tax Ratio | 8.37% | 11.83% | 19.82% | 11.78% | 4.27% | 8.03% | 5.51% | 4.13% | -0.04% | 0.43% | 4.31% | 1.04% | 1.88% |
| Income Tax Expense | 7.01M | 10.84M | 15.48M | 10.97M | 2.36M | 10.86M | 5.72M | -9.72M | 764.23K | -846.90K | 8.59M | 3.15M | 2.77M |
| Net Income | 22.43M | 38.41M | 58.22M | 27.70M | 12.21M | 17.72M | 12.56M | 22.85M | -284.23K | 2.83M | 8.57M | 3.05M | 7.32M |
| Net Income Ratio | 6.61% | 9.32% | 15.69% | 8.53% | 3.79% | 5.06% | 3.92% | 8.28% | -0.10% | 0.71% | 1.95% | 0.66% | 1.59% |
| EPS | 0.06 | 0.10 | 0.15 | 0.07 | 0.03 | 0.05 | 0.03 | 0.06 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 |
| EPS Diluted | 0.06 | 0.10 | 0.15 | 0.07 | 0.03 | 0.05 | 0.03 | 0.06 | 0.00 | 0.01 | 0.02 | 0.01 | 0.02 |
| Weighted Avg Shares Out | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M |
| Weighted Avg Shares Out (Dil) | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M | 383.33M |
Source: https://incomestatements.info
Category: Stock Reports